Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma – significance of potentially retained stemness

by Ju-Yoon Yoon, Christine Brezden-Masley, Catherine J. Streutker
Published 2020-09-01

Cancer and Cardiovascular Disease: The Complex Labyrinth

by Susan Dent, Peter Liu, Christine Brezden-Masley, Daniel Lenihan
Published 2015-01-01

Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.

by Ju-Yoon Yoon, Keiyan Sy, Christine Brezden-Masley, Catherine J Streutker
Published 2019-01-01

Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population

by Amir Abadir, Catherine Streutker, Christine Brezden-Masley, Andrea Grin, Young-In Kim
Published 2012-01-01

Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population

by Catherine Streutker, Young-In Kim, Andrea Grin, Christine Brezden-Masley, Amir Abadir
Published 2012-08-01

Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer

by Christine E. Simmons, Christine Brezden-Masley, Joy McCarthy, Deanna McLeod, Anil Abraham Joy
Published 2020-03-01

Autophagic Heterogeneity in Gastric Adenocarcinoma

by Ju-Yoon Yoon, Ju-Yoon Yoon, Christine Brezden-Masley, Catherine J. Streutker, Catherine J. Streutker
Published 2021-03-01

A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer

by Christine Brezden‐Masley, Kelly E. Fathers, Megan E. Coombes, Behin Pourmirza, Cloris Xue, Katarzyna J. Jerzak
Published 2020-10-01

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

by Joyce O’Shaughnessy, Christine Brezden-Masley, Marina Cazzaniga, Tapashi Dalvi, Graham Walker, James Bennett, Shozo Ohsumi
Published 2020-10-01

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis

by Florence R. Wilson, Megan E. Coombes, Quinlan Wylie, Mariya Yurchenko, Christine Brezden-Masley, Brian Hutton, Becky Skidmore, Chris Cameron
Published 2017-10-01

Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer

by Michelle C. M. Lee, Jacob J. Kachura, Paraskevi A. Vlachou, Raissa Dzulynsky, Amy Di Tomaso, Haider Samawi, Nancy Baxter, Christine Brezden-Masley
Published 2021-08-01

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

by Florence R. Wilson, Megan E. Coombes, Christine Brezden-Masley, Mariya Yurchenko, Quinlan Wylie, Reuben Douma, Abhishek Varu, Brian Hutton, Becky Skidmore, Chris Cameron
Published 2018-11-01

Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study

by Cynthia Maxwell, Sepand Alavifard, Ellen Warner, Maru Barrera, Christine Brezden-Masley, Nicolas Colapinto, Shima Kassirian, Yolanda Madarnas, Sridhar Srikala, Richard Tozer, Joanne Yu, Irena Nulman
Published 2021-08-01

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observati...

by Ashita Barthur, Christine Brezden-Masley, Kim A. Connelly, Vinita Dhir, Kelvin K. W. Chan, Rashida Haq, Anish Kirpalani, Joseph J. Barfett, Laura Jimenez-Juan, Gauri R. Karur, Djeven P. Deva, Andrew T. Yan
Published 2017-04-01

Proceedings From the Global Cardio-Oncology Summit

by Daniel J. Lenihan, MD, Michael G. Fradley, MD, Susan Dent, MD, Christine Brezden-Masley, MD, PhD, Joseph Carver, MD, Roberto Kalil Filho, MD, PhD, Tomas G. Neilan, MD, MPH, Anne Blaes, MD, Chiara Melloni, MD, MHS, Joerg Herrmann, MD, Saro Armenian, DO, MPH, Paaladinesh Thavendiranathan, MD, SM, Gregory T. Armstrong, MD, MSCE, Bonnie Ky, MD, MSCE, Ludhmila Hajjar, MD
Published 2019-12-01